Lista de obras - Luca Vago - Dominio Público Uruguay

A new tool for rapid and reliable diagnosis of HLA loss relapses after HSCT.

artículo científico publicado en 2017

Adjuvant role of SeptiFast to improve the diagnosis of sepsis in a large cohort of hematological patients

artículo científico publicado en 2018

Allogeneic hematopoietic stem cell transplantation for neuromyelitis optica

artículo científico publicado en 2014

Choosing the Alternative.

artículo científico publicado en 2017

Coadministration of posaconazole and sirolimus in allogeneic hematopoietic stem cell transplant recipients.

artículo científico publicado en 2016

Cytokine-induced killer cells are terminally differentiated activated CD8 cytotoxic T-EMRA lymphocytes.

artículo científico publicado en 2009

Droplet digital polymerase chain reaction for DNMT3A and IDH1/2 mutations to improve early detection of acute myeloid leukemia relapse after allogeneic hematopoietic stem cell transplantation.

artículo científico publicado en 2015

Early recovery of CMV immunity after HLA-haploidentical hematopoietic stem cell transplantation as a surrogate biomarker for a reduced risk of severe infections overall

artículo científico publicado en 2015

Elderly patients > 65 years of age with acute myeloid leukemia and normal karyotype benefit from intensive therapeutic programs

artículo científico publicado en 2016

Elevated maternal levels of the long pentraxin 3 (PTX3) in preeclampsia and intrauterine growth restriction

Epidemiology and biology of relapse after stem cell transplantation

artículo científico publicado en 2018

Experts' considerations on HLA-haploidentical stem cell transplantation

artículo científico

Frequency and targeted detection of HLA-DPB1 T cell epitope disparities relevant in unrelated hematopoietic stem cell transplantation.

artículo científico publicado en 2007

Generation of human memory stem T cells after haploidentical T-replete hematopoietic stem cell transplantation.

artículo científico publicado en 2015

Genomic loss of patient-specific HLA in acute myeloid leukemia relapse after well-matched unrelated donor HSCT.

artículo científico publicado en 2012

Genomic typing for patient-specific human leukocyte antigen-alleles is an efficient tool for relapse detection of high-risk hematopoietic malignancies after stem cell transplantation from alternative donors.

artículo científico publicado en 2008

Haploidentical HSCT: a 15-year experience at San Raffaele.

artículo científico publicado en 2015

High rate of hematological responses to sorafenib in FLT3-ITD acute myeloid leukemia relapsed after allogeneic hematopoietic stem cell transplantation.

artículo científico publicado en 2015

Human Herpesvirus 6 Infection Following Haploidentical Transplantation: Immune Recovery and Outcome.

artículo científico publicado en 2016

Immune monitoring in allogeneic hematopoietic stem cell transplant recipients: a survey from the EBMT-CTIWP.

artículo científico publicado en 2018

Immune signature drives leukemia escape and relapse after hematopoietic cell transplantation

scientific article published on 25 March 2019

Improving the safety of cell therapy with the TK-suicide gene

artículo científico publicado en 2015

Incidence, risk factors and clinical outcome of leukemia relapses with loss of the mismatched HLA after partially incompatible hematopoietic stem cell transplantation.

artículo científico publicado en 2014

Infusion of suicide-gene-engineered donor lymphocytes after family haploidentical haemopoietic stem-cell transplantation for leukaemia (the TK007 trial): a non-randomised phase I-II study.

artículo científico publicado en 2009

Integrating a prospective pilot trial and patient-derived xenografts to trace metabolic changes associated with acute myeloid leukemia

artículo científico publicado en 2016

KIR2DS4 is a product of gene conversion with KIR3DL2 that introduced specificity for HLA-A * 11 while diminishing avidity for HLA-C

artículo científico publicado en 2009

Longitudinal qPCR monitoring of nucleophosmin 1 mutations after allogeneic hematopoietic stem cell transplantation to predict AML relapse.

artículo científico publicado en 2015

Loss of mismatched HLA in leukemia after stem-cell transplantation.

artículo científico publicado en 2009

Matching for the nonconventional MHC-I MICA gene significantly reduces the incidence of acute and chronic GVHD.

artículo científico publicado en 2016

Missing HLA C group 1 ligand in patients with AML and MDS is associated with reduced risk of relapse and better survival after allogeneic stem cell transplantation with fludarabine and treosulfan reduced toxicity conditioning.

artículo científico publicado en 2017

NK cell recovery after haploidentical HSCT with posttransplant cyclophosphamide: dynamics and clinical implications.

artículo científico publicado en 2017

NY-ESO-1 TCR single edited stem and central memory T cells to treat multiple myeloma without graft-versus-host disease.

artículo científico publicado en 2017

Non-redundant role of the long pentraxin PTX3 in anti-fungal innate immune response

artículo científico publicado en 2002

Nonpermissive HLA-DPB1 disparity is a significant independent risk factor for mortality after unrelated hematopoietic stem cell transplantation

artículo científico publicado en 2009

PTX3 expression in the heart tissues of patients with myocardial infarction and infectious myocarditis

article by Manuela Nebuloni et al published January 2011 in Cardiovascular Pathology

Post-transplantation Cyclophosphamide and Sirolimus after Haploidentical Hematopoietic Stem Cell Transplantation Using a Treosulfan-based Myeloablative Conditioning and Peripheral Blood Stem Cells

artículo científico publicado en 2015

Post-transplantation cyclophosphamide GvHD prophylaxis after hematopoietic stem cell transplantation from 9/10 or 10/10 HLA-matched unrelated donors for acute leukemia

artículo científico publicado en 2020

Production of the soluble pattern recognition receptor PTX3 by myeloid, but not plasmacytoid, dendritic cells

artículo científico publicado en 2003

Restoring Natural Killer Cell Immunity against Multiple Myeloma in the Era of New Drugs.

artículo científico publicado en 2017

Significantly higher frequencies of alloreactive CD4+ T cells responding to nonpermissive than to permissive HLA-DPB1 T-cell epitope disparities

artículo científico publicado en 2010

Sirolimus-based graft-versus-host disease prophylaxis promotes the in vivo expansion of regulatory T cells and permits peripheral blood stem cell transplantation from haploidentical donors.

artículo científico publicado en 2014

Sorafenib promotes graft-versus-leukemia activity in mice and humans through IL-15 production in FLT3-ITD-mutant leukemia cells.

artículo científico publicado en 2018

T-cell suicide gene therapy prompts thymic renewal in adults after hematopoietic stem cell transplantation.

artículo científico publicado en 2012

Temporal, quantitative, and functional characteristics of single-KIR-positive alloreactive natural killer cell recovery account for impaired graft-versus-leukemia activity after haploidentical hematopoietic stem cell transplantation.

artículo científico publicado en 2008

The impact of amino acid variability on alloreactivity defines a functional distance predictive of permissive HLA-DPB1 mismatches in hematopoietic stem cell transplantation

artículo científico publicado en 2014

The long pentraxin PTX3 as a link among innate immunity, inflammation, and female fertility

artículo científico publicado en 2006

Tracking genetically engineered lymphocytes long-term reveals the dynamics of T cell immunological memory.

artículo científico publicado en 2015

Use of TK-cells in haploidentical hematopoietic stem cell transplantation.

artículo científico publicado en 2012

Lista de obras de Luca Vago

A new tool for rapid and reliable diagnosis of HLA loss relapses after HSCT.

Adjuvant role of SeptiFast to improve the diagnosis of sepsis in a large cohort of hematological patients

Allogeneic hematopoietic stem cell transplantation for neuromyelitis optica

Choosing the Alternative.

Coadministration of posaconazole and sirolimus in allogeneic hematopoietic stem cell transplant recipients.

Cytokine-induced killer cells are terminally differentiated activated CD8 cytotoxic T-EMRA lymphocytes.

Droplet digital polymerase chain reaction for DNMT3A and IDH1/2 mutations to improve early detection of acute myeloid leukemia relapse after allogeneic hematopoietic stem cell transplantation.

Early recovery of CMV immunity after HLA-haploidentical hematopoietic stem cell transplantation as a surrogate biomarker for a reduced risk of severe infections overall

Elderly patients > 65 years of age with acute myeloid leukemia and normal karyotype benefit from intensive therapeutic programs

Elevated maternal levels of the long pentraxin 3 (PTX3) in preeclampsia and intrauterine growth restriction

Epidemiology and biology of relapse after stem cell transplantation

Experts' considerations on HLA-haploidentical stem cell transplantation

Frequency and targeted detection of HLA-DPB1 T cell epitope disparities relevant in unrelated hematopoietic stem cell transplantation.

Generation of human memory stem T cells after haploidentical T-replete hematopoietic stem cell transplantation.

Genomic loss of patient-specific HLA in acute myeloid leukemia relapse after well-matched unrelated donor HSCT.

Genomic typing for patient-specific human leukocyte antigen-alleles is an efficient tool for relapse detection of high-risk hematopoietic malignancies after stem cell transplantation from alternative donors.

Haploidentical HSCT: a 15-year experience at San Raffaele.

High rate of hematological responses to sorafenib in FLT3-ITD acute myeloid leukemia relapsed after allogeneic hematopoietic stem cell transplantation.

Human Herpesvirus 6 Infection Following Haploidentical Transplantation: Immune Recovery and Outcome.

Immune monitoring in allogeneic hematopoietic stem cell transplant recipients: a survey from the EBMT-CTIWP.

Immune signature drives leukemia escape and relapse after hematopoietic cell transplantation

Improving the safety of cell therapy with the TK-suicide gene

Incidence, risk factors and clinical outcome of leukemia relapses with loss of the mismatched HLA after partially incompatible hematopoietic stem cell transplantation.

Infusion of suicide-gene-engineered donor lymphocytes after family haploidentical haemopoietic stem-cell transplantation for leukaemia (the TK007 trial): a non-randomised phase I-II study.

Integrating a prospective pilot trial and patient-derived xenografts to trace metabolic changes associated with acute myeloid leukemia

KIR2DS4 is a product of gene conversion with KIR3DL2 that introduced specificity for HLA-A * 11 while diminishing avidity for HLA-C

Longitudinal qPCR monitoring of nucleophosmin 1 mutations after allogeneic hematopoietic stem cell transplantation to predict AML relapse.

Loss of mismatched HLA in leukemia after stem-cell transplantation.

Matching for the nonconventional MHC-I MICA gene significantly reduces the incidence of acute and chronic GVHD.

Missing HLA C group 1 ligand in patients with AML and MDS is associated with reduced risk of relapse and better survival after allogeneic stem cell transplantation with fludarabine and treosulfan reduced toxicity conditioning.

NK cell recovery after haploidentical HSCT with posttransplant cyclophosphamide: dynamics and clinical implications.

NY-ESO-1 TCR single edited stem and central memory T cells to treat multiple myeloma without graft-versus-host disease.

Non-redundant role of the long pentraxin PTX3 in anti-fungal innate immune response

Nonpermissive HLA-DPB1 disparity is a significant independent risk factor for mortality after unrelated hematopoietic stem cell transplantation

PTX3 expression in the heart tissues of patients with myocardial infarction and infectious myocarditis

Post-transplantation Cyclophosphamide and Sirolimus after Haploidentical Hematopoietic Stem Cell Transplantation Using a Treosulfan-based Myeloablative Conditioning and Peripheral Blood Stem Cells

Post-transplantation cyclophosphamide GvHD prophylaxis after hematopoietic stem cell transplantation from 9/10 or 10/10 HLA-matched unrelated donors for acute leukemia

Production of the soluble pattern recognition receptor PTX3 by myeloid, but not plasmacytoid, dendritic cells

Restoring Natural Killer Cell Immunity against Multiple Myeloma in the Era of New Drugs.

Significantly higher frequencies of alloreactive CD4+ T cells responding to nonpermissive than to permissive HLA-DPB1 T-cell epitope disparities

Sirolimus-based graft-versus-host disease prophylaxis promotes the in vivo expansion of regulatory T cells and permits peripheral blood stem cell transplantation from haploidentical donors.

Sorafenib promotes graft-versus-leukemia activity in mice and humans through IL-15 production in FLT3-ITD-mutant leukemia cells.

T-cell suicide gene therapy prompts thymic renewal in adults after hematopoietic stem cell transplantation.

Temporal, quantitative, and functional characteristics of single-KIR-positive alloreactive natural killer cell recovery account for impaired graft-versus-leukemia activity after haploidentical hematopoietic stem cell transplantation.

The impact of amino acid variability on alloreactivity defines a functional distance predictive of permissive HLA-DPB1 mismatches in hematopoietic stem cell transplantation

The long pentraxin PTX3 as a link among innate immunity, inflammation, and female fertility

Tracking genetically engineered lymphocytes long-term reveals the dynamics of T cell immunological memory.

Use of TK-cells in haploidentical hematopoietic stem cell transplantation.